BRTX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BRTX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
BioRestorative Therapies's total inventories for the quarter that ended in Dec. 2023 was $0.00 Mil. BioRestorative Therapies's average total inventories from the quarter that ended in Sep. 2023 to the quarter that ended in Dec. 2023 was $0.00 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. BioRestorative Therapies's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was $2.13.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. BioRestorative Therapies's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.00.
The historical data trend for BioRestorative Therapies's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioRestorative Therapies Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Total Inventories | Get a 7-Day Free Trial | - | - | - | - | - |
BioRestorative Therapies Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Total Inventories | Get a 7-Day Free Trial | - | - | - | - | - |
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
BioRestorative Therapies (NAS:BRTX) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
BioRestorative Therapies's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is
Net-Net Working Capital Per Share (Q: Dec. 2023 ) | |||||||
= | (Cash And Cash Equivalents | + | 0.75 * Accounts Receivable | + | 0.5 * Total Inventories | - | Total Liabilities |
- | Preferred Stock | - | Minority Interest) | / | Shares Outstanding (EOP) | ||
= | (11.066 | + | 0.75 * 0.019 | + | 0.5 * 0 | - | 1.063 |
- | 0.014 | - | 0) | / | 4.70692 | ||
= | 2.13 |
2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
BioRestorative Therapies's Days Inventory for the three months ended in Dec. 2023 is calculated as:
Days Inventory | = | Average Total Inventories (Q: Dec. 2023 ) | / | Cost of Goods Sold (Q: Dec. 2023 ) | * | Days in Period |
= | 0 | / | 0 | * | 365 / 4 | |
= |
3. Inventory Turnover measures how fast the company turns over its inventory within a year.
BioRestorative Therapies's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as
Inventory Turnover | = | Cost of Goods Sold (Q: Dec. 2023 ) | / | Average Total Inventories (Q: Dec. 2023 ) |
= | 0 | / | 0 | |
= | N/A |
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BioRestorative Therapies's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as
Inventory-to-Revenue | = | Average Total Inventories (Q: Dec. 2023 ) | / | Revenue (Q: Dec. 2023 ) |
= | 0 | / | 0.019 | |
= | 0.00 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Thank you for viewing the detailed overview of BioRestorative Therapies's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.
Dale Broadrick | 10 percent owner | 3003 BRICK CHURCH PIKE, NASHVILLE TN 37207 |
Lance Alstodt | director, 10 percent owner, officer: President, CEO, COB | BIORESTORATIVE THERAPIES, INC., 40 MARCUS DRIVE, SUITE 1, MELVILLE NY 11747 |
Francisco Silva | director, 10 percent owner, officer: VP of Research and Development | STEM CELL ASSURANCE, INC., 555 HERITAGE DRIVE, JUPITER FL 33458 |
Robert Eugene Kristal | officer: Chief Financial Officer | 4719 COLE AVENUE, DALLAS TX 75205 |
Patrick F. Williams | director | C/O ZELTIQ AESTHETICS INC., 4698 WILLOW ROAD, SUITE 100, PLEASANTON CA 94588 |
David A Rosa | director | 10901 RED CIRCLE DRIVE, SUITE 150, MINNETONKA MN 55343 |
Nickolay V. Kukekov | director | 4524 WESTWAY AVE, DALLAS TX 75205 |
Mark Weinreb | director, 10 percent owner, officer: CEO and Chairman of the Board | STEM CELL ASSURANCE, INC., 555 HERITAGE DRIVE, JUPITER FL 33458 |
Paul Jude Tonna | director | 69 CHICHESTER ROAD, HUNTINGTON NY 11743 |
A. Jeffrey Radov | director | 8 WALWORTH AVENUE, SCARSDALE NY 10583 |
Robert Paccasassi | officer: VP, Quality and Compliance | C/O BIORESTORATIVE THERAPIES, INC., 40 MARCUS DRIVE, SUITE 1, MELVILLE NY 11747 |
Robert B Catell | director | 62 OSBORNE ROAD, GARDEN CITY NY 11530 |
Adam D. Bergstein | officer: SVP, Planning and Business Dev | 167 HAZEL AVENUE, GLENCOE IL 60022 |
John M Desmarais | director | 230 PARK AVENUE, NEW YORK NY 10169 |
Westbury Trust | 10 percent owner | VICTORIA HALL, 11 VICTORIA STREET, P.O. BOX HM 1065, HAMILTON D0 00000 |
From GuruFocus
By sperokesalga sperokesalga • 05-15-2023
By sperokesalga sperokesalga • 06-16-2023
By Marketwired • 07-11-2023
By Value_Insider Value_Insider • 12-05-2022
By ACCESSWIRE • 07-07-2023
By ACCESSWIRE ACCESSWIRE • 05-12-2023
By sperokesalga sperokesalga • 05-04-2023
By ACCESSWIRE • 07-31-2023
By sperokesalga sperokesalga • 03-02-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.